Ian Mortimer, CFO & COO at Xenon Pharmaceuticals Inc. (XENE), bought 5,300 shares at $6.15 ($33K) on 2016-06-24, disclosed to the SEC on 2016-06-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.10 | 1,000 | $6K | 18.5% |
| 2 | $6.15 | 1,000 | $6K | 18.7% |
| 3 | $6.25 | 2,000 | $13K | 37.9% |
| 4 | $6.30 | 1,300 | $8K | 24.9% |
| Total | $6.22 avg | 5,300 | $33K | 100% |
| Filing → |
| XENE | SELL | 2026-03-11 | $17.6M | — | Filing → |
| XENE | SELL | 2026-01-02 | $1.8M | — | Filing → |
| XENE | SELL | 2025-12-09 | $2.3M | — | Filing → |